Erythrocyte deformability reduction in various pediatric hematologic diseases.

Area of Science:

• Pediatric Hematology
• Hemorheology
• Erythrocyte Physiology

Background:

• Previous hemorheology research using Rheoscan primarily focused on adult chronic diseases.
• Studies utilizing LORCA concentrated on erythrocyte disorders, but Rheoscan had not been applied to pediatric hematologic conditions.
• This study addresses a gap in understanding erythrocyte function in pediatric hematologic diseases.

Purpose of the Study:

• To investigate and compare erythrocyte deformability in children diagnosed with iron deficiency anemia (IDA), hereditary spherocytosis (HS), immune thrombocytopenia (ITP), and aplastic anemia (AA).
• To establish baseline erythrocyte elongation index (EI) values for these pediatric hematologic conditions and compare them to healthy controls.

Main Methods:

• A cohort of 43 pediatric patients (7 HS, 8 IDA, 6 AA, 9 ITP) and 13 healthy controls were analyzed.
• Erythrocyte deformability was quantitatively assessed using a microfluidic ektacytometer (RheoScan-D).
• The erythrocyte elongation index (EI) was calculated to measure deformability.

Main Results:

• Significantly decreased EI values were observed in patients with IDA, HS, and AA compared to healthy controls.
• Patients with ITP exhibited EI values comparable to those of healthy children.
• These findings indicate distinct hemorheological profiles across different pediatric hematologic diseases.

Conclusions:

• Erythrocyte deformability varies significantly among different pediatric hematologic diseases.
• The diagnostic and prognostic implications of altered erythrocyte deformability in these conditions warrant further investigation.
• This research underscores the potential of hemorheology as a biomarker in pediatric hematology.